{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:24:27Z","timestamp":1785803067815,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004008","name":"National Institute of Health","doi-asserted-by":"publisher","award":["RIPREI2023"],"award-info":[{"award-number":["RIPREI2023"]}],"id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P4-0092"],"award-info":[{"award-number":["P4-0092"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P4-0165"],"award-info":[{"award-number":["P4-0165"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0201"],"award-info":[{"award-number":["P1-0201"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P2-0152"],"award-info":[{"award-number":["P2-0152"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P2-0421"],"award-info":[{"award-number":["P2-0421"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0179"],"award-info":[{"award-number":["P1-0179"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P4-0463"],"award-info":[{"award-number":["P4-0463"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100026893","name":"Center for Advancing Research Impact in Society","doi-asserted-by":"publisher","award":["I0-0022"],"award-info":[{"award-number":["I0-0022"]}],"id":[{"id":"10.13039\/100026893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032338","name":"Kemijski in\u0161titut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007675","name":"International Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010790","name":"Erasmus Plus","doi-asserted-by":"publisher","award":["2023-1-SI01-KA131-HED-000122972"],"award-info":[{"award-number":["2023-1-SI01-KA131-HED-000122972"]}],"id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioorg.2026.109949","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:19:41Z","timestamp":1778084381000},"page":"109949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus"],"prefix":"10.1016","volume":"178","author":[{"given":"Nina","family":"Kobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Dreisewerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Luk\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matic","family":"Pavlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uro\u0161","family":"Gro\u0161elj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u010crtomir","family":"Podlipnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Janc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017diva","family":"Lengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polona","family":"Mrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Tu\u0161ek \u017dnidari\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maru\u0161a","family":"Pompe Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ur\u0161ka","family":"Kuhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hostnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Dattola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Carletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polona","family":"Kogov\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109949_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MRM.0000000000000386","article-title":"COVID-19 Omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic","volume":"36","author":"Mahmoud","year":"2025","journal-title":"Rev. Res. Med. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109949_bb0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-023-06649-6","article-title":"A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes","volume":"623","author":"Sanderson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109949_bb0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41586-023-06609-0","article-title":"Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir","volume":"622","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109949_bb0025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(23)00011-7","article-title":"Real-world use of nirmatrelvir\u2013ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study","volume":"23","author":"Aggarwal","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.109949_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114242","article-title":"SARS-CoV-2 E protein: pathogenesis and potential therapeutic development","volume":"159","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109949_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12985-023-02095-y","article-title":"Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2","volume":"20","author":"Breitinger","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.bioorg.2026.109949_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104445","article-title":"Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission","volume":"85","author":"Laha","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10930-021-09988-3","article-title":"In silico study of mutational stability of SARS-CoV-2 proteins","volume":"40","author":"Chaudhuri","year":"2021","journal-title":"Protein J."},{"key":"10.1016\/j.bioorg.2026.109949_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.105097","article-title":"Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome","volume":"96","author":"Omotoso","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0055","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1128\/JVI.77.8.4597-4608.2003","article-title":"The small envelope protein E is not essential for murine coronavirus replication","volume":"77","author":"Kuo","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2011.03.029","article-title":"Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein","volume":"415","author":"Nieto-Torres","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0065","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JVI.74.5.2333-2342.2000","article-title":"Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E","volume":"74","author":"Raamsman","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0070","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1128\/JVI.72.10.7885-7894.1998","article-title":"Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly","volume":"72","author":"Fischer","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0075","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1128\/JVI.76.3.1422-1434.2002","article-title":"Heterologous gene expression from transmissible gastroenteritis virus replicon particles","volume":"76","author":"Curtis","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02325-17","article-title":"Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis","volume":"9","author":"Casta\u00f1o-Rodriguez","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.bioorg.2026.109949_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2015.02.005","article-title":"Coronavirus envelope (E) protein remains at the site of assembly","volume":"478","author":"Venkatagopalan","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0090","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41594-020-00536-8","article-title":"Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers","volume":"27","author":"Mandala","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0095","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1113\/JP281037","article-title":"The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH","volume":"599","author":"Cabrera-Garcia","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41422-021-00519-4","article-title":"SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target","volume":"31","author":"Xia","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2026.109949_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.virol.2005.08.022","article-title":"Substitution of the transmembrane domain of Vpu in simian\u2013human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza a results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques","volume":"344","author":"Hout","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virol.2005.04.038","article-title":"Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques","volume":"339","author":"Hout","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0115","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/JVI.76.3.1391-1399.2002","article-title":"Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture","volume":"76","author":"Takeda","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1083\/jcb.133.4.733","article-title":"The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus","volume":"133","author":"Sakaguchi","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s002490100177","article-title":"Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu","volume":"31","author":"Ewart","year":"2002","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.bioorg.2026.109949_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/mol.115.102731","article-title":"Mechanisms of action of novel influenza a\/M2 viroporin inhibitors derived from hexamethylene amiloride","volume":"90","author":"Jalily","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.virol.2006.05.028","article-title":"Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication","volume":"353","author":"Wilson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(03)01453-4","article-title":"Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride","volume":"557","author":"Premkumar","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2026.109949_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza a(H3N2) and a(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.109949_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jmgm.2008.06.002","article-title":"How amantadine and rimantadine inhibit proton transport in the M2 protein channel","volume":"27","author":"Intharathep","year":"2008","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2026.109949_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.692423","article-title":"Inhibition of SARS CoV envelope protein by flavonoids and classical viroporin inhibitors","volume":"12","author":"Breitinger","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0160","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41401-021-00732-2","article-title":"Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2026.109949_bb0165","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/acs.jpcb.5c02898","article-title":"Advanced computational approaches to evaluate the potential of new-generation adamantane-based drugs as Viroporin inhibitors: a case study on SARS-CoV-2","volume":"129","author":"Yousefbeigi","year":"2025","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2026.109949_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2025.06.036","article-title":"In silico determination of novel SARS-CoV-2 envelope protein ion channel inhibitors","author":"Kobe","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bioorg.2026.109949_bb0175","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbrc.2019.02.105","article-title":"The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor","volume":"511","author":"Cui","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.109949_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.943783","article-title":"Potential mouse models of coronavirus-related immune injury","volume":"13","author":"Nan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/mps5010005","article-title":"Optimized protocols for the propagation and quantification of infectious murine hepatitis virus (MHV-A59) using NCTC clone 1469 and 929 cells","volume":"5","author":"Shuipys","year":"2022","journal-title":"Methods Protoc."},{"key":"10.1016\/j.bioorg.2026.109949_bb0190","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1128\/JVI.76.21.11065-11078.2002","article-title":"Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59","volume":"76","author":"Yount","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0200","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1039\/C9CC01330J","article-title":"Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer\u2019s disease","volume":"55","author":"Meden","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.109949_bb0205","series-title":"Data for: In silico characterisation of a novel SARS-CoV-2 Envelope protein inhibitor and in vitro validation against Murine coronavirus","author":"Kobe","year":"2025"},{"key":"10.1016\/j.bioorg.2026.109949_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cmi.12029","article-title":"Virus factories: biogenesis and structural design: biogenesis and architecture of virus factories","volume":"15","author":"De Castro","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0215","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s00018-020-03745-y","article-title":"Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release","volume":"78","author":"Eymieux","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2026.109949_bb0220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109949_bb0225","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/jmv.26598","article-title":"Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19","volume":"93","author":"Podder","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114242","article-title":"SARS-CoV-2 E protein: pathogenesis and potential therapeutic development","volume":"159","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109949_bb0235","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s42003-021-02866-9","article-title":"Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro","volume":"4","author":"Toft-Bertelsen","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0240","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.109949_bb0245","article-title":"All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: a real-world observational study","volume":"20","author":"Mancilla-Galindo","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.bioorg.2026.109949_bb0250","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.virol.2012.07.005","article-title":"Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids","volume":"432","author":"Verdi\u00e1-B\u00e1guena","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0255","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1110\/ps.062730007","article-title":"Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein","volume":"16","author":"Torres","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2026.109949_bb0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.bioorg.2026.109949_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030103","article-title":"Hepatitis C virus p7 protein is crucial for assembly and release of infectious Virions","volume":"3","author":"Steinmann","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2026.109949_bb0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00018-023-04889-3","article-title":"The expanding organelle lipidomes: current knowledge and challenges","volume":"80","author":"Sarmento","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2026.109949_bb0275","doi-asserted-by":"crossref","first-page":"20995","DOI":"10.1021\/acsami.1c02755","article-title":"Glycyrrhizic acid nanoparticles as antiviral and anti-inflammatory agents for COVID-19 treatment","volume":"13","author":"Zhao","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioorg.2026.109949_bb0280","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.02360-06","article-title":"Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models","volume":"81","author":"Burrer","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0285","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/v13102082","article-title":"Efficacy of ion-channel inhibitors amantadine, memantine and rimantadine for the treatment of SARS-CoV-2 in vitro","volume":"13","author":"Zhou","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.109949_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009519","article-title":"Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity","volume":"17","author":"Park","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2026.109949_bb0295","series-title":"Antiviral Methods and Protocols","year":"2013"},{"key":"10.1016\/j.bioorg.2026.109949_bb0300","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"Chen","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0305","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001571","article-title":"Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels","volume":"102","author":"Breitinger","year":"2021","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0310","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.22555","article-title":"Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel","volume":"48","author":"Griffin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0315","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/JVI.01467-06","article-title":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo","volume":"81","author":"DeDiego","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004320","article-title":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis","volume":"10","author":"Jimenez-Guarde\u00f1o","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2026.109949_bb0325","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s11658-025-00758-y","article-title":"The SARS-CoV-2 envelope PDZ binding motif acts as a virulence factor disrupting host\u2019s epithelial cell\u2013cell junctions","volume":"30","author":"Alvarez","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bioorg.2026.109949_bb0330","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virol.2007.05.032","article-title":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway","volume":"368","author":"Ortego","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0335","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00426-23","article-title":"Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells","volume":"97","author":"Miura","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0340","doi-asserted-by":"crossref","first-page":"eadl5012","DOI":"10.1126\/sciadv.adl5012","article-title":"ER-export and ARFRP1\/AP-1\u2013dependent delivery of SARS-CoV-2 envelope to lysosomes controls late stages of viral replication","volume":"10","author":"Pearson","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109949_bb0345","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260685","article-title":"SARS-CoV-2 infection alkalinizes the ERGIC and lysosomes through the viroporin activity of the viral envelope protein","volume":"136","author":"Wang","year":"2023","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bioorg.2026.109949_bb0350","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.cell.2020.10.039","article-title":"\u0392-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway","volume":"183","author":"Ghosh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109949_bb0355","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1128\/JVI.72.11.8636-8643.1998","article-title":"Coronavirus Pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes","volume":"72","author":"Baudoux","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0360","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/viro.1999.9955","article-title":"Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells","volume":"263","author":"Maeda","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109949_bb0365","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1128\/JVI.74.9.4319-4326.2000","article-title":"Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles","volume":"74","author":"Corse","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0370","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2014 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109949_bb0375","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2026.109949_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:57:32Z","timestamp":1783123052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"alternative-id":["S0045206826004852"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109949","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109949"}}